A Safety, Pharmacokinetic, and Pharmacodynamic Study of Once Daily Inhaled AZD8630 in Adults With Asthma
Clinical trial NCT06795906 · COMPLETED
Trial details
- NCT number
- NCT06795906
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-28
- Primary completion
- 2025-06-27
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.